 |
 |
 |
Search Stock:
Bafna Pharmaceuticals Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Bafna Pharmaceuticals (BAFNAPH) Key Ratios
P/E
Company73.62
Sector6.74
A Price-to-Earnings of 73.62 means investors pay 73.62 units per 1 unit of earnings. This is higher than the sector average of 6.74.
P/B
Company-0.49
Sector4.35
A P/B ratio of -0.49 shows market value relative to book value. This is lower than the sector average of 4.35.
ROA
Company-45.61%
Sector-17.9%
Return on Assets shows a -45.61% profit per unit of asset. This is higher than the sector average of -17.9%.
ROE
Company11.54%
Sector-3.17%
Return on Equity creates 11.54% profit per unit of equity. This is higher than the sector average of -3.17%.
ROCE
Company10.63%
Sector6.29%
ROCE indicates 10.63% operating earnings per unit of capital. This is higher than the sector average of 6.29%.
Quick Ratio
Company1.44
Sector6.91
The Quick Ratio is 1.44 compared to sector average 6.91.
EV/EBITDA
Company0.16
Sector14.55
EV/EBITDA of 0.16 means value is 0.16 times core earnings. This is lower than the sector average of 14.55.
Bafna Pharmaceuticals Share Price Analysis API (Live)
Bafna Pharmaceuticals share price is ₹312.60, day high (share price) is ₹318.50, day low (share price) is ₹301.00 and volume is 28,133. 52 Week high share price for Bafna Pharmaceuticals is ₹318.50 on 01 Sep 2026 and 52 week low share price for Bafna Pharmaceuticals is ₹91.20 on 25 Aug 2025. Price data as of: 01 Sep, 2026 3:31 PM.
According to latest price data (as of 01 Sep, 2026 3:31 PM) for Bafna Pharmaceuticals share, 14 day period RSI (Relative Strength Index) is 75.8 (O.Bought), 50 DMA (50 Displaced Moving Average) is 242.85 and 200 DMA (200 Displaced Moving Average) is 162.55.
▲
₹312.60
8.35 (2.74%)
As of 01 Sep, 2026
Open
₹307.00
Day High - Low
₹318.50 - ₹301.00
Volume
28,133
52 Weeks High
₹318.50
on 01 Sep 2026
52 Weeks Low
₹91.20
on 25 Aug 2025
RSI (14)
75.8 (O.Bought)
50 DMA
242.85
200 DMA
162.55
Loading...
Bafna Pharmaceuticals (BAFNAPH) Technical Analysis
₹312.60
+8.35
01 Sep, 2026
Bafna Pharmaceuticals Technical Data and Analysis available in multiple timeframes.
Bafna Pharmaceuticals Oscillators Analysis
On the Day timeframe, the outlook for BAFNAPH is: The long-term trend is Positive (Price vs 200 SMA) and RSI (14) is: 75.8.
Bafna Pharmaceuticals Price Action
Bafna Pharmaceuticals Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 75.82 |
| Stoch %K (14, 3, 3) | 96.92 |
| CCI (20) | 164.46 |
| ADX (14) | 32.58 |
| Awesome Osc | 30.28 |
| Momentum (10) | 65.10 |
| MACD (12, 26, 9) | 14.43 |
| MACD Signal | 10.54 |
| Stoch RSI (14) | 97.35 |
| Williams %R (14) | -6.90 |
| Bull/Bear Power | 65.05 |
| Ultimate Osc | 80.15 |
| MFI (14) | 78.15 |
| ROC (21) | 16.55 |
| ROC (125) | 196.87 |
| ATR (14) | 9.32 |
Bafna Pharmaceuticals Moving Averages
BAFNAPH is trading above 14 out of 14 SMAs.
312.60
CURRENT PRICE
Bullish Moving Averages
14
Bearish Moving Averages
0
5 SMA293.21
8 SMA278.79
9 SMA274.22
10 SMA271.06
12 SMA267.55
20 SMA270.06
21 SMA270.22
26 SMA267.85
30 SMA264.21
34 SMA259.89
50 SMA242.85
100 SMA193.09
150 SMA166.84
200 SMA162.55
| Ichimoku Base | 275.73 | Above Base |
| VWMA (20) | 283.33 | Above VWMA |
| HMA (9) | 310.76 | Above HMA |
Bafna Pharmaceuticals Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- MACD is above the signal line and in positive territory, reflecting supportive momentum.
WEAKNESSES
- No notable technical weakness signals are currently observed.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- RSI is overbought, which may increase the likelihood of short-term consolidation or pullback.
- Price is near the upper Bollinger Band, which can indicate strong momentum or possible exhaustion.
Bafna Pharmaceuticals Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 324.25 | 328.98 | 308.28 | 314.95 |
| Resistance 2 | 314.95 | 317.31 | 306.94 | 309.35 |
| Resistance 1 | 309.60 | 314.33 | 305.59 | 305.90 |
| Pivot Point | 300.30 | 302.66 | 304.25 | 300.30 |
| Support 1 | 294.95 | 299.68 | 302.91 | 294.70 |
| Support 2 | 285.65 | 288.01 | 301.56 | 291.25 |
| Support 3 | 280.30 | 285.03 | 300.22 | 285.65 |
Records:
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
Records:
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Bafna Pharmaceuticals - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 75.00% | 75.00% | 75.00% | 75.00% |
| FII | 9.34% | 9.34% | 9.34% | 9.34% |
| DII (Other) | 0.00% | 0.00% | 0.00% | 0.00% |
| Retail & Others | 15.66% | 15.66% | 15.66% | 15.66% |
| Mutual Funds | 0.00% | 0.00% | 0.00% | 0.00% |
Bafna Pharmaceuticals - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2019 | 44.01 -43.94% | -17.28 -17.39% | -18.35 -8.52% |
| Mar 2018 | 78.50 +18.76% | -14.72 +27.7% | -16.91 +13.1% |
| Mar 2017 | 66.10 -24.28% | -20.36 -32.9% | -19.46 -28.53% |
| Mar 2016 | 87.30 | -15.32 | -15.14 |
No corporate actions data available.
Bafna Pharmaceuticals Share Price and Volume Historical Data
Synchronizing MarketBandhu Database...